Upstream Bio Inc
NASDAQ:UPB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Upstream Bio Inc
NASDAQ:UPB
|
US |
|
SAP SE
F:SAP
|
DE |
|
C
|
Church & Crawford Inc
OTC:CCWF
|
US |
|
P
|
Pinnacle West Capital Corp
LSE:0KIT
|
US |
Intrinsic Value
Is UPB undervalued or overvalued?
See the intrinsic value estimate for
Upstream Bio Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Upstream Bio Does
Upstream Bio is a clinical-stage biotechnology company that is developing antibody medicines for severe inflammatory and respiratory diseases. Its lead programs are aimed at the biology that drives conditions such as asthma and chronic sinus disease, with the goal of calming the overactive immune signals that keep these illnesses going.
- Headquarters
- United States of America US
- Employees
- 75
- IPO date
- Oct 11, 2024
Earnings Waterfall
Upstream Bio Inc
The intrinsic value for
Upstream Bio Inc (UPB) under the Base Case is hidden USD.
Compared with the current market price of 2.98 USD, the stock appears hidden.